Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Other Non-Current Assets (2019 - 2025)

Korro Bio (KRRO) has disclosed Other Non-Current Assets for 6 consecutive years, with $3.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Assets rose 50.28% year-over-year to $3.2 million, compared with a TTM value of $3.2 million through Sep 2025, up 50.28%, and an annual FY2024 reading of $2.8 million, up 3.06% over the prior year.
  • Other Non-Current Assets was $3.2 million for Q3 2025 at Korro Bio, down from $3.2 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $3.2 million in Q2 2025 and bottomed at $228000.0 in Q4 2022.
  • Average Other Non-Current Assets over 5 years is $2.0 million, with a median of $1.8 million recorded in 2021.
  • The sharpest move saw Other Non-Current Assets plummeted 82.42% in 2021, then skyrocketed 1090.35% in 2023.
  • Year by year, Other Non-Current Assets stood at $320000.0 in 2021, then dropped by 28.75% to $228000.0 in 2022, then surged by 1090.35% to $2.7 million in 2023, then increased by 3.06% to $2.8 million in 2024, then grew by 13.37% to $3.2 million in 2025.
  • Business Quant data shows Other Non-Current Assets for KRRO at $3.2 million in Q3 2025, $3.2 million in Q2 2025, and $3.2 million in Q1 2025.